| ankylosing spondylitis pain medication drugstore white magic lovers psoriatic arthritis pain management mercury drug store makati drugstore pharmacy toronto pain management sickle cell disease pain medicine vicodin harmful prescription drugs pain medication lists best pain medicine for shingles bartells drug store west seattle prescription drugs list effexor online pharmacy tooth pain relief medicine interstitial cystitis pain medication enbrel rheumatoid arthritis treatment buy prescription medicines best drug store shampoos cheap prescription drugs without prescription anesthesiology pain management joint pain relief products high cost prescription drugs tramadol hydrochloride 50mg ultram generic tramadol discount chemist warehouse australia tramadol hcl tab mylan chemist career objective tramadol hcl acetaminophen back exercises for pain relief online drugstore prescription Terry White Chemist Sydney |
Many people have resorted to buying painkillers online to save money or because they can get painkillers cheap compared to their local pharmacy. Adjusting fioricetfor these items and the fourth quarter special items, income from continuing operations for the full year ended would have been $1.8 million, or $0.05 per diluted share. For the full year 2008, Par reported a loss of $47.8 million, or $1.43 per share. "This momentum should continue into 2009 as the results of our restructuring takes hold and solid product sales continue." In October, Par announced its plans to resize its generic division by significantly reducing its research and development expense and trimming its product portfolio resulting in a workforce reduction of approximately 190. For and other company information, visit. Revenues from fioricetPar's generic segment declined 28.3% for the full year 2008 to $491.1 million primarily due to competitive pressures that adversely affected buy cheap zithromaxthe volume and pricing of certain existing products. Painkillers - Why You Should NOT Buy Painkillers Online - Nurse's Secret Report Recently even more warnings have been issued about buying painkillers online without a prescription or with a prescription. This is compared with reported net income of $49.9 million, or $1.43 per share in 2007. If they have manipulated the chemical compound the drugs may be less potent than they claim to be. A replay of the conference call will be available pain medicationcommencing approximately one hour after the call. These benefits were tempered by $19.2 million of costs related to business development activities in support of Strativa Pharmaceuticals, Par's branded division, a $6.0 million loss on an investment, $1.6 million of severance costs. Par reported a loss for the fourth quarter ended of $32.0 million, or $0.96 per share. Recent research by bionova skincare bloga major university found that there are dozens of websites that sell prescription only painkillers but don't ask for proof of prescription. Adjusting for these items, income from continuing prescription drugsoperations for the full year ended would have been $55.1 million, or $1.59 per diluted share. Narcotic painkillers and opioids are powerful drugs and have many side effects, risks and adverse reactions. For the fourth quarter ended , Par reported total revenues of $161.3 million and a loss from continuing operations of $30.5 million, or $0.91 per share. To the prozac nation reviewsextent any statements made in this news release contain information that is not historical, these statements are essentially forward-looking and, as such, are subject to known and unknown risks, uncertainties and contingencies, many of which pain medicationare beyond the control of the Company, which could cause actual results and outcomes to differ materially from those expressed herein. SOURCE Par Pharmaceutical Companies, Inc.. Revenues for the fourth quarter 2008 increased 4.0% compared with the same period in 2007 due primarily to the launch of sumatriptan pain relief drugssuccinate injection, increased sales of metoprolol and Megace(R) ES. Ordering drugs on the Internet may seem cheap but in may hurt your health or even kill you. Some combinations can kill you. Adjusting for these items, income from continuing operations for the fourth quarter of 2007 would have been $6.5 million, or $0.19 per diluted share. Adjusting for these items and other special items, income from continuing operations for the fourth quarter 2008 would have been drug store$7.1 million, or $0.21 per diluted share. Par anticipates these actions will generate annualized operating expense savings in a range near $45 million. Some of these websites asked for a prescription but accepted a faxed-in verapamilcopy of their prescription or an emailed copy of their prescription which could easily be tampered with, changed or even completely forged. Safe Harbor Statement Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. This is compared with reported revenues of $155.1 million and income from continuing operations of $5.5 million, or $0.16 per diluted pain medicineshare, for the same period in 2007. Generic product famciclovir and uti sgross margin decreased to 22.2% of generic revenues in 2008 from 29.8% of generic revenues in 2007 driven by increased sales of lower margin metoprolol succinate, lower sales of existing products as mentioned above, and an impairment charge of $4.9 million for nabumetone, and lower inventory write-offs, in addition to the other factors discussed above. The $15.4 million fourth quarter charge related to the restructuring will result in cash expenditures of approximately $6.0 million in 2009. The decrease was due primarily to a net reduction of $11.7 million of one-time Strativa milestone payments. LePore, chairman, president pain pillsand chief executive officer. Products which experienced significant volume buy viagra online cheapand pricing declines included fluticasone, propranolol, cabergoline, various amoxicillin products, ranitidine syrup, tramadol HCl and acetaminophen tablets driven by Par's exit from the market, and lower royalty payments of ondansetron tablets, among others. For the year ended , Par reported total revenues of $578.1 million and a loss from continuing operations of $45.9 million, or $1.38 per share. This is compared with reported revenues of $769.7 million and income from continuing operations of $51.1 million, or $1.47 per diluted share, for 2007. So you may not know what you are getting. As of , Par had working capital of $193.8 million, which includes $142 million of current liabilities due to mature in September 2010. The decrease in SG&A expense was primarily due to lower employee compensation, the non-recurrence of the 2007 stock option tender offer and the resulting lower stock option costs, and ultracetlower expenses relates to sales and marketing of Megace(R) ES, which offset higher legal fees, severance costs and increased outside consulting costs. Many countries have become experts on duplicating and coming up with imitations and it may include painkiller drugs. For a copy of Par's 2008 Annual Report on Form 10-K, visit Investors/SEC Filings on the Par web site at. So to be on the safe side it's best not to buy painkillers online unless you know the pharmacy, preferably a local pharmacy, and they require proper proof of your painkiller prescription. You may be innocently taking them for pain treatmentpain and found you are becoming physically dependent on them or have an actual pain killer addiction. The replay dial-in number is 888-286-8010 for domestic callers and 617-801-6888 for international callers. One problem you don't hear much about is the fact that in many cases you may not know where the drug was manufactured. It could be in China or other countries. This is just one more than one reason why someone should not buy painkillers without a prescription online. For the year ended total revenue decreased 24.9% to $578 million pain killerscompared with the same period a year earlier as a result of a decrease in the number of new product launches, trimming of Par's generic product portfolio, increased competition in Par's generic products. Revenues from Strativa represented 15.1% of total revenues, as compared to 11.0% in 2007. These decreases were offset by higher sales of meclizine, which re-launched in July, the launch of dronabinol in July, and the launch of sumatriptan succinate in November, simvastatin dosageand increased sales of metoprolol succinate to new customers. Par's 2008 gross margin represented 30.5% of total revenues, a decrease from 34.9% in 2007. By comparison, fourth quarter 2007 results included a pre-tax gain of $3.1 million from Par's sale of its remaining investment in Optimer Pharmaceutical, Inc. Generic R&D expense decreased $8.0 million due to lower internal development costs, lower pain pillsperformance incentive compensation of $4 million, and the non-recurrence of one-time costs associated with a third party development agreement. Research and development (R&D) expenses decreased 23.2% from the year ended , to $59.7 million, and represented 10.3% of total revenues. To buy painkillers online comes with its risks a lot of hazards and warnings that go along with it. Risk factors that might affect such forward-looking statements include those set forth in Item 1A of the Company's Annual Report on Form 10-K for the year ended , in other of the Company's filings with painthe SEC from time to time, including Current Reports on Form 8-K, and on general industry and economic conditions. And combined with alcohol they can be deadly. Some of these websites did not even ask for any proof that the buyer had a prescription.sweating curing side effects in antibioticsmedicine Par Pharmaceutical Reports Fourth Quarter and Full Year 2008 Results WOODCLIFF LAKE, N.J., / - / -- Par Pharmaceutical Companies, Inc. The dial-in number is 888-679-8034 for domestic callers and 617-213-4847 for international callers. Access to the live webcast can be made via Par's website at and will be available for 30 days. Fourth quarter 2008 reported, or GAAP, loss from continuing operations also included the write-off of a restructuring charge of $15.4 million and other related costs of $3.8 million, $49.2 million in charges due to an unfavorable court decision and related legal fees, pain meds$5.3 million gain on non-core ANDA sales and the sale of other product rights, $4.9 million impairment charge related to various investments, and a $7.9 million gain related to carlo debt extinguishment. glipizideStrativa's gross margin increased to 77.7% of branded revenues from 76.0% in 2007 due to revenue growth discussed above. Develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. This is compared with reported net income of $4.3 million, or $0.12 per share, for the same period in 2007. Par's reported, or GAAP, loss from continuing operations for the year ended , included the write-off of an intangible asset and certain inventories related to prescription medicationthe trimming of its generic product portfolio of $5.5 million, a charge related to a government pricing contingency of $4.8 million, a $7.8 million net impairment charge related to various investments, $7.5 million in development milestone payments to MonoSol Rx and Alfacell, and $9.0 million of gains from the sale of non-core ANDAs and other product rights. They usually have a totally cymbaltadifferent response if they are taken with another drug and doctors know what drugs they can be combined with or not. Par invites investors and the general public to listen to a webcast of the conference call. Unfortunately there are many online pharmacies that have been selling opioids and other painkillers without a prescription, for popular pain killers such as Oxycodone, hydrocodone, Oxycontin, Vicodin, Percocet, codeine, Tramadol and many others. Strativa revenues increased 2.7% from the prior year to $87.1 million driven by a mid-year price increase, ayurvedic skin carefees related to the co-promotion of Androgel(R), and timing of trade buying patterns offset by a more challenging reimbursement environment. You don't know what you're getting whether you have a painkiller prescription or not. Some of these painkillers are usually prescribed in combination with other medications and drugs or medications taken by someone who has not seen a doctor and been legally prescribed, can lead to some serious health consequences. "Given the challenging environment of 2008, we are pleased with the operating results over the last two quarters," stated Ignace G. Com stock and $4.6 million of additional share-based compensation expense related to Par's employee stock option tender offer. PRX) today reported fourth quarter and full year 2008 results ended. On-going R&D expense in support of Par's strategy to expand Strativa increased $1.7 million driven by costs related to the development of Zensana(TM). Par Pharmaceutical Companies, Inc. Par has scheduled a conference call for at 9:00 am EST to discuss results for the fourth quarter and full year 2008. Many of these narcotic painkillers can be addictive and it can happen before you know it. Selling, General and Administrative Selling, general and administrative (SG&A) expense of $137.9 million for the year ended decreased slightly from $138.2 million in 2007. By comparison, and in addition to the fourth quarter 2007 events cited above, reported GAAP income from continuing operations for the full year 2007 included a $20.0 million gain on the sale to Optimer of marketing rights to the investigational drug Difimicin (Par 101), a $4.5 million investment gain on the sale of shares of Optimer com stock, and net settlement gains of $0.6 million. Any forward-looking statements included in this news release are made as of the date hereof only, based on information available to the Company as of the date hereof, and, subject to any applicable law to the contrary, the Company assumes no obligation to update any forward-looking statements. |
|
 | |||||||||||||||||||||||||||||||||
